---
title: "RIGL: Rigel licensed VEPPANU from Arvinas/Pfizer for $70M upfront plus milestones and royalties"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294865550.md"
description: "Rigel secured an exclusive global license for VEPPANU (Vepdegestrant) from Arvinas and Pfizer, paying $70M upfront plus milestones and royalties, and amended its credit facility to permit the transaction. The agreement grants Rigel full commercial rights and responsibilities, with robust compliance and termination provisions, and positions VEPPANU for commercial launch in August 2026.Original document: Rigel Pharmaceuticals, Inc. [RIGL] SEC 10-Q Quarterly Report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-04T20:17:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294865550.md)
  - [en](https://longbridge.com/en/news/294865550.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294865550.md)
generator: "portal-rs"
---

# RIGL: Rigel licensed VEPPANU from Arvinas/Pfizer for $70M upfront plus milestones and royalties

Rigel secured an exclusive global license for VEPPANU (Vepdegestrant) from Arvinas and Pfizer, paying $70M upfront plus milestones and royalties, and amended its credit facility to permit the transaction. The agreement grants Rigel full commercial rights and responsibilities, with robust compliance and termination provisions, and positions VEPPANU for commercial launch in August 2026.

Original document: Rigel Pharmaceuticals, Inc. \[RIGL\] SEC 10-Q Quarterly Report — Aug. 4 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [RIGL.US](https://longbridge.com/en/quote/RIGL.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ARVN.US](https://longbridge.com/en/quote/ARVN.US.md)

## Related News & Research

- [Medicus Pharma signs co-development, licensing deal with Pfizer for CD228V antibody-drug conjugate](https://longbridge.com/en/news/297910433.md)
- [Archer Investment Corp Acquires Shares of 73,546 Pfizer Inc. $PFE](https://longbridge.com/en/news/297393723.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [UBS says 'physical AI' is here, and shares 3 picks-and-shovels sectors of the market to play the trade.](https://longbridge.com/en/news/297929372.md)
- [The Bot Now Clicks Buy: Your AI Is About To Start Spending Your Money](https://longbridge.com/en/news/297424265.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**